Alexandros Michailidis
Pfizer (PFE) is considering suing Metsera (MTSR) and potentially Novo Nordisk (NVO) after the Danish drugmaker topped Pfizer’s offer.
Pfizer (PFE) argues that the structure of the deal skirts regulatory approvals and was previously rejected by Metsera (